SCHEMBL874151

SCHEMBL874151

CCNc1nc(-c2ccc(NC(=O)c3cc4cccnc4s3)cc2)ccc1C(=O)NCCN1CC[S+]([O-])CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
KCNH2 Q12809 1/20 0.40
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40
CHRNA7 P36544 2/20 0.36
NAMPT P43490 2/20 0.36
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ATR Q13535 2/20 0.34
KDM5B Q9UGL1 6/20 0.34
HPGDS O60760 1/20 0.33
MCHR1 Q99705 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874686 0.92 CYP3A4 (0.42) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL873657 0.86 CYP3A4 (0.41) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL874082 0.85 MAPT (0.38) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL874570 0.84 MOK (0.43) DRD2DRD3CHRNA7KDM4EMAPT
SCHEMBL874837 0.83 KMT2A (0.37) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL874152 0.83 CHRNA7 (0.37) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL874515 0.83 ATR (0.43) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL875385 0.82 MAPT (0.40) CYP3A4CYP2D6CYP2C9KCNH2CHRNA7
SCHEMBL873820 0.81 ATR (0.46) CYP3A4CYP2D6CYP2C9KCNH2DRD2
SCHEMBL874015 0.81 DRD2 (0.41) KCNH2DRD2DRD3CHRNA7NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed